Collaboration Details

Print  Close


Title of Collaborative Activity:

NIH-FDA Interagency Clinical Outcome Assessments Working Group

Description of Collaborative Activity:

The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation, and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research. COAs include any measurement tool that is not purely objective and may be patient-reported, clinician-reported, or observer-reported in nature.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:

2010

NIH Participating Institutes/Centers/Office of the Director:

CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/DPCPSI

HHS Agency Collaborators on this Activity:

FDA